Oil prices fall 1% as economic worries outweigh tanker tensions
NEW YORK (Reuters) – Oil prices fell more than 1% on Monday after more poor Chinese economic figures fanned fears of lower worldwide oil demand. FILE PHOTO: An oil rig…
GSK pharma head flags need for speed in high-pressure drug market
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford any longer, the head of pharmaceuticals at Britain’s largest drugmaker…
VBI’s shares plunge after hep B vaccine fails secondary goal in late-stage trial
(Reuters) – VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an…
U.S. Navy official sees more orders for Boeing P-8A in coming months
PARIS (Reuters) – The U.S. Navy expects additional U.S. and international orders for the Boeing P-8A Poseidon maritime patrol aircraft in coming months, which should extend production by two years…
Exclusive: Boeing seeking to reduce scope, duration of some physical tests for new aircraft – sources
PARIS (Reuters) – Boeing Co engineers are reducing the scope and duration of certain costly physical tests used to certify the planemaker’s new aircraft, according to industry sources and regulatory…
Boeing says will take time to win back confidence
PARIS (Reuters) – The head of Boeing said on Sunday the U.S. planemaker had made a mistake in implementing a faulty cockpit warning system on the 737 MAX and predicted…
Boeing crisis, trade tensions cast pall over air show
PARIS (Reuters) – Safety concerns, trade wars and growing security tensions in the Gulf are dampening spirits at the world’s largest planemakers as they arrive at this week’s Paris Airshow…
NATO faces big bill if it does not pick AWACS successor soon: officials
PARIS (Reuters) – NATO faces significant costs if it does not act soon to choose a successor for its ageing fleet of 14 Boeing E-3A Airborne Warning & Control System…
Take Five: The Fed and the rest
With President Donald Trump’s trade policies heightening fears of a U.S. recession, expectations of a Fed rate cut have dramatically increased in the past month. Money market pricing became even…
Bluebird prices gene therapy at 1.58 million euros over 5 years
(Reuters) – Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe…